PGY1 Community-Based Pharmacy Residency with Revelation Pharma - Innovation Compounding

PGY1 residency programs build upon Doctor of Pharmacy education and outcomes to develop pharmacist
practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and
objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient
care, practice management, leadership, and education, and be prepared to provide patient care, seek board
certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including
postgraduate year two (PGY2) residencies.

In addition to patient care experiences commonly encountered in community-based pharmacy settings, the
Revelation Pharma - Innovation Compounding PGY1 Community-Based Pharmacy Residency offers additional
training opportunities in sterile and nonsterile compounding, clinical research and formulation development,
business administration, and pharmacy advocacy. The Revelation Pharma - Innovation Compounding PGY1
Community-Based Pharmacy Residency prepares pharmacist practitioners to serve as highly qualified
independent practitioners who are able to:

• demonstrate expertise in the field of sterile and nonsterile compounding;
• optimize patient outcomes through personalized medication management and utilization of novel formulations to meet individualized needs of patients;
• develop, create, implement, and adhere to sophisticated quality assurance programs;
• navigate the intricate regulatory landscape surrounding compounding and ensure adherence to guidelines set by the FDA, USP, and PCAB;
• identify and implement efficiencies to increase pharmacy productivity while controlling costs; and
• serve in managerial roles within community pharmacies.

Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative, quality and personalized pharmaceutical preparations, products, and services through "industry best" patient care and solutions for customers. The company serves tens of thousands of prescribers and hundreds of thousands of patients nationwide each year.  With a geographic footprint in all 50 states and the virtual telemedicine realm, Revelation has a reach to service patients and healthcare providers nationwide, thereby further increasing patient access to the highest quality compounded medications. Revelation Pharma’s therapeutic scope spans several areas of medicine including Women’s Health, Men’s Health, Dermatology and Cosmeceuticals, Anti-Infective, IV/IM Nutrition, Weight Management, Animal Health (for veterinary field), Ophthalmic/Eye Care, Allergy Immunotherapy, and Functional Medicine. In addition to its support of today’s customers through its patient-first services and solutions, Revelation Pharma is actively furthering the compounding industry through a robust wholesaling arm, a quality control and assurance team, and a clinical team that includes ongoing research and development. Management specializes in pharmaceutical innovation, mergers and acquisitions, organic service and geographic expansion, patient advocacy, wholesale, consulting services, research and development, patient-reported outcomes measures research, clinical training and education for patients and prescribers, and regulation and compliance.  Revelation Pharma’s Clinical team meets every 2 weeks and includes Clinical Liaison pharmacists, PGY1 Community-Based Pharmacy Residents, and a Consultative Care Coordinator.  

Innovation Compounding is a 503A pharmacy located in Kennesaw, Georgia that services local patients as well as patients nationwide across 48 states.  This PCAB-accredited facility contains a sterile and non-sterile lab.  Therapeutic lines at this site include but are not limited to:

• Women's health – menopause, sexual dysfunction, pelvic pain
• Men's health – hypogonadism, erectile dysfunction, benign prostatic hyperplasia
• Weight loss management
• Nutrition therapy
• Pain management – chronic pain
• Cosmeceutical/dermatological – acne vulgaris, stretch marks, atopic dermatitis

The average prescription load is 1,500 per day with up to 350 patient phone calls.